Cargando…

Development of a benchmarking toolkit for adolescent and young adult rheumatology services (BeTAR)

BACKGROUND: Young people (YP; 12–24 years old) with rheumatic diseases face many challenges associated with chronic illness in addition to the physiological and psychosocial changes of adolescence. Timely access to developmentally appropriate multidisciplinary care is key to successfully managing rh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Ran A., Chaplin, Hema, Livermore, Polly, Lee, Martin, Sen, Debajit, Wedderburn, Lucy R., Wilkinson, Nick, Jeffery, Rachel, Kempa, Andrea, Norton, Imogen, Tattersall, Rachel, Ioannou, Yiannis, Eleftheriou, Despina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528251/ https://www.ncbi.nlm.nih.gov/pubmed/31113443 http://dx.doi.org/10.1186/s12969-019-0323-8

Ejemplares similares

Developing and Evaluating JIApp: Acceptability and Usability of a Smartphone App System to Improve Self-Management in Young People With Juvenile Idiopathic Arthritis
por: Cai, Ran A, et al.
Publicado: (2017)

Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis
por: Wu, Qiong, et al.
Publicado: (2016)

OA27 Growth of the UK and Ireland paediatric rheumatology nurses’ group
por: Rostron, Heather, et al.
Publicado: (2022)

The benefits of a peer-support group for paediatric rheumatology nurses working in isolation
por: Rostron, Heather, et al.
Publicado: (2022)

Association of Anxiety With Pain and Disability but Not With Increased Measures of Inflammation in Adolescent Patients With Juvenile Idiopathic Arthritis
por: Hanns, Laura, et al.
Publicado: (2020)

The lived experience of juvenile idiopathic arthritis in young people receiving etanercept
por: Livermore, P, et al.
Publicado: (2016)

PEGylated drugs in rheumatology—why develop them and do they work?
por: McDonnell, Thomas, et al.
Publicado: (2014)

Physicochemical Characterization of Mining Waste from the Betare-Oya Gold Area (East Cameroon) and an Adsorption Test by Sabga Smectite (North-West Cameroon)
por: Luc Leroy, Mambou Ngueyep, et al.
Publicado: (2020)

P49 The Barbara Ansell National Network for Adolescent Rheumatology – 10 years on
por: Yorke, Sarah, et al.
Publicado: (2022)

Benchmarking of the BITalino biomedical toolkit against an established gold standard
por: Batista, Diana, et al.
Publicado: (2019)

Tar
Publicado: (1895)

TarTar: A Timed Automata Repair Tool
por: Kölbl, Martin, et al.
Publicado: (2020)

The Performance of Quantiferon TB Gold In-Tube as a Screening Tool in Paediatric Rheumatology prior to Initiation of Infliximab: A Single Centre's Experience
por: Maritsi, Despoina, et al.
Publicado: (2011)

Tar baby
por: Morrison, Toni
Publicado: (1987)

On Tar Fumigation
por: Ward, H.
Publicado: (1821)

Syrup of Tar
Publicado: (1889)

Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study
por: McErlane, Flora, et al.
Publicado: (2016)

Tumour necrosis factor-α levels are elevated in adolescent patients with juvenile idiopathic arthritis on etanercept therapy
por: Radziszewska, Anna, et al.
Publicado: (2014)

Inflammatory Changes of the Lumbar Spine in Children and Adolescents With Enthesitis-Related Arthritis: Magnetic Resonance Imaging Findings
por: Vendhan, Kanimozhi, et al.
Publicado: (2014)

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
por: Ll Wilkinson, Meredyth G., et al.
Publicado: (2021)

Inflammatory lesions of the orbit: a single paediatric rheumatology centre experience
por: Boulter, EL, et al.
Publicado: (2011)

Coal tar creosote /
por: Melber, C.
Publicado: (2004)

The Coal-Tar Derivatives
por: Duncan, J. W.
Publicado: (1895)

Coal Tar Antipyretics
por: Martin, J. A.
Publicado: (1896)

The Coal Tar Derivatives
por: Duncan, J. W.
Publicado: (1895)

Tar in Skin Diseases
Publicado: (1875)

Tar Smoke for Diphtheria
Publicado: (1884)

Depressive symptoms, pain and disability for adolescent patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study
por: Hanns, Laura, et al.
Publicado: (2018)

Application of Benzo(a)pyrene and Coal Tar Tumor Dose–Response Data to a Modified Benchmark Dose Method of Guideline Development
por: Fitzgerald, D. James, et al.
Publicado: (2004)

UK paediatric rheumatology and its clinical trials network
por: Beresford, MW, et al.
Publicado: (2008)

Carcinogenic Constituents of Coal-tar
por: Berenblum, I., et al.
Publicado: (1947)

Coal Tar and Paving Products
por: Schulte, Paul A.
Publicado: (2006)

Tar Ointment in Chronic Eczema
por: Basu, B. D.
Publicado: (1891)

New Process for Tar-Water
Publicado: (1873)

The Antiseptic Properties of Tar Water
por: Wright, Thos. R.
Publicado: (1878)

The Coal Tar Products Again
Publicado: (1910)

In Vitro Evaluation of Bis-3-Chloropiperidines as RNA Modulators Targeting TAR and TAR-Protein Interaction
por: Sosic, Alice, et al.
Publicado: (2022)

Effect of Sulfur on Wood Tar Biopitch as a Sustainable Replacement for Coal Tar Pitch Binders
por: Shah, Zeban, et al.
Publicado: (2023)

Being on the juvenile dermatomyositis rollercoaster: a qualitative study
por: Livermore, Polly, et al.
Publicado: (2019)

YIM-P59. Relationships between the Th17 and innate lymphoid cell signature in enthesitis related arthritis
por: Lom, Hannah, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ikd2f0mhb1u8jc6533g8n7pfau